Home

Bioworkshops sell "Emicizumab"

Basic Information

1.4K
93
7
4.6(50)

Trade Type

Sell

Product Name

Emicizumab

Manufacturer(s)

Specifications

  • Expression System: Developed from a proprietary mammalian cell line supported by a Drug Master File (DMF) filing, enabling global regulatory submissions
  • Purity: Proven high degree of analytical comparability to the reference product (emicizumab, bispecific FIXa/FX-mimetic antibody, CAS 1610943-06-0), supporting regulatory and clinical acceptance
  • Application: Bispecific antibody mimicking activated Factor IX and Factor X (biosimilar), representative indication hemophilia A; originator approved in the United States in 2017

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product